205 related articles for article (PubMed ID: 22037650)
1. PET-guided dose escalation tomotherapy in malignant pleural mesothelioma.
Fodor A; Fiorino C; Dell'Oca I; Broggi S; Pasetti M; Cattaneo GM; Gianolli L; Calandrino R; Di Muzio NG
Strahlenther Onkol; 2011 Nov; 187(11):736-43. PubMed ID: 22037650
[TBL] [Abstract][Full Text] [Related]
2. Tomotherapy PET-guided dose escalation: A dosimetric feasibility study for patients with malignant pleural mesothelioma.
Maggio A; Cutaia C; Di Dia A; Bresciani S; Miranti A; Poli M; Del Mastro E; Garibaldi E; Gabriele P; Stasi M
Strahlenther Onkol; 2016 Feb; 192(2):102-8. PubMed ID: 26453534
[TBL] [Abstract][Full Text] [Related]
3. Moderately Hypofractionated Helical IMRT, FDG-PET/CT-guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs.
Fodor A; Broggi S; Incerti E; Dell'Oca I; Fiorino C; Samanes Gajate AM; Pasetti M; Cattaneo MG; Passoni P; Gianolli L; Calandrino R; Picchio M; Di Muzio N
Clin Lung Cancer; 2019 Jan; 20(1):e29-e38. PubMed ID: 30253920
[TBL] [Abstract][Full Text] [Related]
4. Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma.
Kishan AU; Cameron RB; Wang PC; Alexander S; Qi SX; Low DA; Kupelian PA; Steinberg ML; Lee JM; Selch MT; Lee P
Pract Radiat Oncol; 2015; 5(6):366-73. PubMed ID: 26432677
[TBL] [Abstract][Full Text] [Related]
5. Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung.
Minatel E; Trovo M; Polesel J; Rumeileh IA; Baresic T; Bearz A; Del Conte A; Franchin G; Gobitti C; Drigo A; Dassie A; Pagan V; Trovo MG
J Thorac Oncol; 2012 Dec; 7(12):1862-1866. PubMed ID: 23154558
[TBL] [Abstract][Full Text] [Related]
6. Erratum to: Tomotherapy PET-guided dose escalation--A dosimetric feasibility study for patients with malignant pleural mesothelioma.
Maggio A; Cutaia C; Di Dia A; Bresciani S; Miranti A; Poli M; Delmastro E; Garibaldi E; Gabriele P; Stasi M
Strahlenther Onkol; 2015 Dec; 191(12):987. PubMed ID: 26545763
[TBL] [Abstract][Full Text] [Related]
7. Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment.
Basu S; Saboury B; Torigian DA; Alavi A
Mol Imaging Biol; 2011 Oct; 13(5):801-11. PubMed ID: 21136185
[TBL] [Abstract][Full Text] [Related]
8. Does selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation? : A planning study.
Botticella A; Defraene G; Nackaerts K; Deroose C; Coolen J; Nafteux P; Vanstraelen B; Joosten S; Michiels LAW; Peeters S; De Ruysscher D
Strahlenther Onkol; 2017 Apr; 193(4):285-294. PubMed ID: 28197653
[TBL] [Abstract][Full Text] [Related]
9. Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals.
Bille A; Belcher E; Raubenheimer H; Landau D; Cane P; Spicer J; Lang-Lazdunski L
Gen Thorac Cardiovasc Surg; 2012 May; 60(5):289-96. PubMed ID: 22453539
[TBL] [Abstract][Full Text] [Related]
10. Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study.
Botticella A; Defraene G; Nackaerts K; Deroose CM; Coolen J; Nafteux P; Peeters S; Ricardi U; De Ruysscher D
Acta Oncol; 2016 Dec; 55(12):1450-1455. PubMed ID: 27732127
[TBL] [Abstract][Full Text] [Related]
11. An individualized radiation dose escalation trial in non-small cell lung cancer based on FDG-PET imaging.
Wanet M; Delor A; Hanin FX; Ghaye B; Van Maanen A; Remouchamps V; Clermont C; Goossens S; Lee JA; Janssens G; Bol A; Geets X
Strahlenther Onkol; 2017 Oct; 193(10):812-822. PubMed ID: 28733723
[TBL] [Abstract][Full Text] [Related]
12. High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment.
Parisi E; Romeo A; Sarnelli A; Ghigi G; Bellia SR; Neri E; Micheletti S; Dipalma B; Arpa D; Furini G; Burgio MA; Genestreti G; Gurioli C; Sanna S; Bovolato P; Rea F; Storme G; Scarpi E; Arienti C; Tesei A; Polico R
Cancer Radiother; 2017 Dec; 21(8):766-773. PubMed ID: 29132803
[TBL] [Abstract][Full Text] [Related]
13. FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival.
Gerbaudo VH; Mamede M; Trotman-Dickenson B; Hatabu H; Sugarbaker DJ
Eur J Nucl Med Mol Imaging; 2011 May; 38(5):810-21. PubMed ID: 21210110
[TBL] [Abstract][Full Text] [Related]
14. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
Patel PR; Yoo S; Broadwater G; Marks LB; Miles EF; D'Amico TA; Harpole D; Kelsey CR
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):362-8. PubMed ID: 22516382
[TBL] [Abstract][Full Text] [Related]
15. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
[TBL] [Abstract][Full Text] [Related]
16. Comparison of CT and integrated PET-CT based radiation therapy planning in patients with malignant pleural mesothelioma.
Pehlivan B; Topkan E; Onal C; Nursal GN; Yuksel O; Dolek Y; Yavuz MN; Yavuz AA
Radiat Oncol; 2009 Sep; 4():35. PubMed ID: 19758456
[TBL] [Abstract][Full Text] [Related]
17. [Value of tomotherapy in malignant pleural mesothelioma: first clinical results].
Giraud P; Sylvestre A; Lisbona A; Zefkili S; Bonnette P; Le Pimpec Barthes F; Michaud JL; Perigaud C; Mahé MA
Rev Mal Respir; 2011 May; 28(5):609-17. PubMed ID: 21645831
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of postoperative highly conformal versus 3D conformal radiotherapy in patients with malignant pleural mesothelioma.
Krayenbuehl J; Dimmerling P; Ciernik IF; Riesterer O
Radiat Oncol; 2014 Jan; 9():32. PubMed ID: 24456714
[TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma.
Ahamad A; Stevens CW; Smythe WR; Vaporciyan AA; Komaki R; Kelly JF; Liao Z; Starkschall G; Forster KM
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):768-75. PubMed ID: 12573764
[TBL] [Abstract][Full Text] [Related]
20. Helical tomotherapy for resected malignant pleural mesothelioma: dosimetric evaluation and toxicity.
Giraud P; Sylvestre A; Zefkili S; Lisbona A; Bonnette P; Le Pimpec Barthes F; Paris E; Perigaud C; Savignoni A; Mahé MA
Radiother Oncol; 2011 Nov; 101(2):303-6. PubMed ID: 21864923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
